Treatment Outcomes in People With Migraine Receiving Rimegepant or Triptans: A Descriptive Analysis From A Real-world Survey
Abraham L,Brown J,Hygge-blakeman K,Dai F,Jackson J,Whitton W,Barlow S,Hancock L
AAN 2025
- 美国神经病学学会年会 2025
| 偏头痛
A Retrospective Cohort Study Comparing Persistence Between Rimegepant and Oral Triptans for the Acute Treatment of Migraine in the US
Jenkins A, Atkinson J, Dai F, Ho M, Lewis M, Henrikson C, Abraham L
AAN 2025
- 美国神经病学学会年会 2025
| 偏头痛
Evaluating the effect of rimegepant or oral triptans on patient-reported outcomes among adults with migraine in the United States
Dagenais S, Ailani J, Chen N, Dai F, Cirillo J, Hygge Blakeman K, Turko A
AAN 2025
- 美国神经病学学会年会 2025
| 偏头痛
Interim Analysis of CONFIDENCE: A Prospective Observational Study With Acute Treatment of Rimegepant ODT on Consistency, Satisfaction, and Tolerability of Treatment in the Real World
Abraham L, Urani A, Lambru G, Lipton RB, Goadsby PJ, Pozo-Rosich P, Schwedt TJ, Galabova B, Dai F, Hygge-Blakeman K
AAN 2025
- 美国神经病学学会年会 2025
| 偏头痛
The Emerging Role of Digital Opinion Leaders in the Migraine Social Media Landscape
Monteith TS,Verduzco-gutierrez M,Ehrlich A,Moran H,Riggins N,Starling AJ,Fajardo M,Sweeney S
AAN 2025
- 美国神经病学学会年会 2025
| 偏头痛
